Medium materiality6/10
Revolution Medicines price target raised to $259 from $251 at RBC Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital raises Revolution Medicines target to $259 from $251; current price $183.52.
- Target $259 (from $251); price $183.52; RBC Capital
Key facts
- 01
Target: $259
- 02
Posted price: $183.52
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.